Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 38 entries
Sorted by: Best Match Show Resources per page
Long-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant.

Ophthalmology and therapy

Bertelmann T, Schulze S.
PMID: 25672501
Ophthalmol Ther. 2015 Jun;4(1):51-8. doi: 10.1007/s40123-015-0028-0. Epub 2015 Feb 12.

INTRODUCTION: This case study aims to evaluate outcomes following fluocinolone acetonide [FAc 0.2 μg/day; ILUVIEN(®) (Alimera Sciences Limited, Aldershot, UK)] implant in a patient with diabetic macular edema (DME) not responding to laser photocoagulation or anti-vascular endothelial growth factor...

Cite
Bertelmann T, Schulze S. Long-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant. Ophthalmol Ther. 2015;4(1):51-8doi: 10.1007/s40123-015-0028-0.
Bertelmann, T., & Schulze, S. (2015). Long-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant. Ophthalmology and therapy, 4(1), 51-8. https://doi.org/10.1007/s40123-015-0028-0
Bertelmann, Thomas, and Schulze, Stephan. "Long-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant." Ophthalmology and therapy vol. 4,1 (2015): 51-8. doi: https://doi.org/10.1007/s40123-015-0028-0
Bertelmann T, Schulze S. Long-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant. Ophthalmol Ther. 2015 Jun;4(1):51-8. doi: 10.1007/s40123-015-0028-0. Epub 2015 Feb 12. PMID: 25672501; PMCID: PMC4470980.
Copy Download .nbib Format: NLM
Significance of the disc damage likelihood scale objectively measured by a non-mydriatic fundus camera in preperimetric glaucoma.

Clinical ophthalmology (Auckland, N.Z.)

Pahlitzsch M, Torun N, Erb C, Bruenner J, Maier AK, Gonnermann J, Bertelmann E, Klamann MK.
PMID: 26640365
Clin Ophthalmol. 2015 Nov 20;9:2147-58. doi: 10.2147/OPTH.S93213. eCollection 2015.

PURPOSE: To assess the correlation between the disc damage likelihood scale (DDLS) objectively measured by a non-mydriatic fundus camera, Heidelberg Retina Tomograph 3, and optic coherence tomography in preperimetric glaucoma.METHODS: One-hundred-twenty-five patients with preperimetric primary open-angle glaucoma (POAG) and...

Cite
Pahlitzsch M, Torun N, Erb C, et al. Significance of the disc damage likelihood scale objectively measured by a non-mydriatic fundus camera in preperimetric glaucoma. Clin Ophthalmol. 2015;9:2147-58doi: 10.2147/OPTH.S93213.
Pahlitzsch, M., Torun, N., Erb, C., Bruenner, J., Maier, A. K., Gonnermann, J., Bertelmann, E., & Klamann, M. K. (2015). Significance of the disc damage likelihood scale objectively measured by a non-mydriatic fundus camera in preperimetric glaucoma. Clinical ophthalmology (Auckland, N.Z.), 92147-58. https://doi.org/10.2147/OPTH.S93213
Pahlitzsch, Milena, et al. "Significance of the disc damage likelihood scale objectively measured by a non-mydriatic fundus camera in preperimetric glaucoma." Clinical ophthalmology (Auckland, N.Z.) vol. 9 (2015): 2147-58. doi: https://doi.org/10.2147/OPTH.S93213
Pahlitzsch M, Torun N, Erb C, Bruenner J, Maier AK, Gonnermann J, Bertelmann E, Klamann MK. Significance of the disc damage likelihood scale objectively measured by a non-mydriatic fundus camera in preperimetric glaucoma. Clin Ophthalmol. 2015 Nov 20;9:2147-58. doi: 10.2147/OPTH.S93213. eCollection 2015. PMID: 26640365; PMCID: PMC4662372.
Copy Download .nbib Format: NLM
Consumption of calcium antagonists: results of the German national health surveys.

Pharmacoepidemiology and drug safety

Knopf H, Melchert HU, Bertelsmann A.
PMID: 19025823
Pharmacoepidemiol Drug Saf. 2000 May;9(3):221-33. doi: 10.1002/1099-1557(200005/06)9:3<221::AID-PDS499>3.0.CO;2-P.

PURPOSE: In generating firm conclusions concerning the efficacy and safety of drugs, the description of the exposed population should be one of the first steps in pharmacoepidemiological studies. The present investigation describes the frequency of usage and calcium antagonists...

Cite
Knopf H, Melchert HU, Bertelsmann A. Consumption of calcium antagonists: results of the German national health surveys. Pharmacoepidemiol Drug Saf. 2000;9(3):221-33doi: 10.1002/1099-1557(200005/06)9:3<221::AID-PDS499>3.0.CO;2-P.
Knopf, H., Melchert, H. U., & Bertelsmann, A. (2000). Consumption of calcium antagonists: results of the German national health surveys. Pharmacoepidemiology and drug safety, 9(3), 221-33. https://doi.org/10.1002/1099-1557(200005/06)9:3<221::AID-PDS499>3.0.CO;2-P
Knopf, H, et al. "Consumption of calcium antagonists: results of the German national health surveys." Pharmacoepidemiology and drug safety vol. 9,3 (2000): 221-33. doi: https://doi.org/10.1002/1099-1557(200005/06)9:3<221::AID-PDS499>3.0.CO;2-P
Knopf H, Melchert HU, Bertelsmann A. Consumption of calcium antagonists: results of the German national health surveys. Pharmacoepidemiol Drug Saf. 2000 May;9(3):221-33. doi: 10.1002/1099-1557(200005/06)9:3<221::AID-PDS499>3.0.CO;2-P. PMID: 19025823.
Copy Download .nbib Format: NLM
Can dynamic contour tonometry and ocular pulse amplitude help to detect severe cardiovascular pathologies?.

Clinical ophthalmology (Auckland, N.Z.)

Bertelmann T, Langanke S, Potstawa M, Strempel I.
PMID: 25075172
Clin Ophthalmol. 2014 Jul 14;8:1317-21. doi: 10.2147/OPTH.S63182. eCollection 2014.

We demonstrate the close relationship between a conspicuous ocular pulse amplitude and severe underlying cardiovascular disease. Two otherwise symptom-free glaucoma patients without any previously diagnosed underlying cardiovascular pathology but with a conspicuous ocular pulse amplitude and who underwent routine...

Cite
Bertelmann T, Langanke S, Potstawa M, et al. Can dynamic contour tonometry and ocular pulse amplitude help to detect severe cardiovascular pathologies?. Clin Ophthalmol. 2014;8:1317-21doi: 10.2147/OPTH.S63182.
Bertelmann, T., Langanke, S., Potstawa, M., & Strempel, I. (2014). Can dynamic contour tonometry and ocular pulse amplitude help to detect severe cardiovascular pathologies?. Clinical ophthalmology (Auckland, N.Z.), 81317-21. https://doi.org/10.2147/OPTH.S63182
Bertelmann, T, et al. "Can dynamic contour tonometry and ocular pulse amplitude help to detect severe cardiovascular pathologies?." Clinical ophthalmology (Auckland, N.Z.) vol. 8 (2014): 1317-21. doi: https://doi.org/10.2147/OPTH.S63182
Bertelmann T, Langanke S, Potstawa M, Strempel I. Can dynamic contour tonometry and ocular pulse amplitude help to detect severe cardiovascular pathologies?. Clin Ophthalmol. 2014 Jul 14;8:1317-21. doi: 10.2147/OPTH.S63182. eCollection 2014. PMID: 25075172; PMCID: PMC4106920.
Copy Download .nbib Format: NLM
Prevalence of Back Pain among German Ophthalmologists.

Ophthalmic research

Bertelmann T, Heutelbeck A, Bopp S, Sagebiel LL, Eichberg S, Hallier E, Hilgers R, Quiering C, Hoerauf H.
PMID: 34348327
Ophthalmic Res. 2021;64(6):974-982. doi: 10.1159/000517574. Epub 2021 Jul 22.

INTRODUCTION: The aim of this study was to evaluate the prevalence of back pain among German ophthalmologists, to investigate the relationship towards age, gender, various profession-related factors, to correlate localization of pain to subspecialties, and to explore individual therapeutic...

Cite
Bertelmann T, Heutelbeck A, Bopp S, et al. Prevalence of Back Pain among German Ophthalmologists. Ophthalmic Res. 2021;64(6):974-982doi: 10.1159/000517574.
Bertelmann, T., Heutelbeck, A., Bopp, S., Sagebiel, L. L., Eichberg, S., Hallier, E., Hilgers, R., Quiering, C., & Hoerauf, H. (2021). Prevalence of Back Pain among German Ophthalmologists. Ophthalmic research, 64(6), 974-982. https://doi.org/10.1159/000517574
Bertelmann, Thomas, et al. "Prevalence of Back Pain among German Ophthalmologists." Ophthalmic research vol. 64,6 (2021): 974-982. doi: https://doi.org/10.1159/000517574
Bertelmann T, Heutelbeck A, Bopp S, Sagebiel LL, Eichberg S, Hallier E, Hilgers R, Quiering C, Hoerauf H. Prevalence of Back Pain among German Ophthalmologists. Ophthalmic Res. 2021;64(6):974-982. doi: 10.1159/000517574. Epub 2021 Jul 22. PMID: 34348327.
Copy Download .nbib Format: NLM
Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics.

Scientific reports

Bertelmann T, Berndzen L, Raber T, Pfeiffer S, Leha A, Paul C, Feltgen N, Bemme S.
PMID: 34916576
Sci Rep. 2021 Dec 16;11(1):24096. doi: 10.1038/s41598-021-03509-z.

The primary objective was to create and establish a new formula that predicts the individual probability of macular hole closure for eyes with full thickness macular holes (FTMH) accompanied by vitreomacular traction (VMT) which received enzymatic vitreolysis using intravitreally...

Cite
Bertelmann T, Berndzen L, Raber T, et al. Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics. Sci Rep. 2021;11(1):24096doi: 10.1038/s41598-021-03509-z.
Bertelmann, T., Berndzen, L., Raber, T., Pfeiffer, S., Leha, A., Paul, C., Feltgen, N., & Bemme, S. (2021). Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics. Scientific reports, 11(1), 24096. https://doi.org/10.1038/s41598-021-03509-z
Bertelmann, Thomas, et al. "Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics." Scientific reports vol. 11,1 (2021): 24096. doi: https://doi.org/10.1038/s41598-021-03509-z
Bertelmann T, Berndzen L, Raber T, Pfeiffer S, Leha A, Paul C, Feltgen N, Bemme S. Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics. Sci Rep. 2021 Dec 16;11(1):24096. doi: 10.1038/s41598-021-03509-z. PMID: 34916576; PMCID: PMC8677762.
Copy Download .nbib Format: NLM
Selective Laser Trabeculoplasty Versus MIGS: Forgotten Art or First-Step Procedure in Selected Patients with Open-Angle Glaucoma.

Ophthalmology and therapy

Pahlitzsch M, Davids AM, Winterhalter S, Zorn M, Reitemeyer E, Klamann MKJ, Torun N, Bertelmann E, Maier AK.
PMID: 33963524
Ophthalmol Ther. 2021 Sep;10(3):509-524. doi: 10.1007/s40123-021-00347-0. Epub 2021 May 07.

INTRODUCTION: To evaluate the long-term effect on intraocular pressure (IOP) and glaucoma medication of selective laser trabeculoplasty (SLT) compared to minimally invasive glaucoma surgery (MIGS) in primary open-angle glaucoma (POAG) and its potential in clinical practice.METHODS: A total of...

Cite
Pahlitzsch M, Davids AM, Winterhalter S, et al. Selective Laser Trabeculoplasty Versus MIGS: Forgotten Art or First-Step Procedure in Selected Patients with Open-Angle Glaucoma. Ophthalmol Ther. 2021;10(3):509-524doi: 10.1007/s40123-021-00347-0.
Pahlitzsch, M., Davids, A. M., Winterhalter, S., Zorn, M., Reitemeyer, E., Klamann, M. K. J., Torun, N., Bertelmann, E., & Maier, A. K. (2021). Selective Laser Trabeculoplasty Versus MIGS: Forgotten Art or First-Step Procedure in Selected Patients with Open-Angle Glaucoma. Ophthalmology and therapy, 10(3), 509-524. https://doi.org/10.1007/s40123-021-00347-0
Pahlitzsch, Milena, et al. "Selective Laser Trabeculoplasty Versus MIGS: Forgotten Art or First-Step Procedure in Selected Patients with Open-Angle Glaucoma." Ophthalmology and therapy vol. 10,3 (2021): 509-524. doi: https://doi.org/10.1007/s40123-021-00347-0
Pahlitzsch M, Davids AM, Winterhalter S, Zorn M, Reitemeyer E, Klamann MKJ, Torun N, Bertelmann E, Maier AK. Selective Laser Trabeculoplasty Versus MIGS: Forgotten Art or First-Step Procedure in Selected Patients with Open-Angle Glaucoma. Ophthalmol Ther. 2021 Sep;10(3):509-524. doi: 10.1007/s40123-021-00347-0. Epub 2021 May 07. PMID: 33963524; PMCID: PMC8319229.
Copy Download .nbib Format: NLM
Treatment of Philadelphia Chromosome Positive (Ph +) Chronic Myelogenous Leukemia in Blast Crisis and Ph + Acute Leukemia with High Dose Cytosine Arabinoside (HDARAC).

Leukemia & lymphoma

Kempin S, Arlin Z, Berman E, Gee T, Mertelsmann R, Andreeff M, Kolitz J, Jhanwar S, Myers J, Clarkson B.
PMID: 27462940
Leuk Lymphoma. 1991;4(2):111-6. doi: 10.3109/10428199109068053.

High dose cytosine arabinoside (HDARAC) was administered to eleven patients in the blastic phase of Philadelphia (Ph) chromosome positive chronic myelogenous leukemia (CML). Four patients presented in blastic phase and in seven patients blastic transformation had evolved from a...

Cite
Kempin S, Arlin Z, Berman E, et al. Treatment of Philadelphia Chromosome Positive (Ph +) Chronic Myelogenous Leukemia in Blast Crisis and Ph + Acute Leukemia with High Dose Cytosine Arabinoside (HDARAC). Leuk Lymphoma. 1991;4(2):111-6doi: 10.3109/10428199109068053.
Kempin, S., Arlin, Z., Berman, E., Gee, T., Mertelsmann, R., Andreeff, M., Kolitz, J., Jhanwar, S., Myers, J., & Clarkson, B. (1991). Treatment of Philadelphia Chromosome Positive (Ph +) Chronic Myelogenous Leukemia in Blast Crisis and Ph + Acute Leukemia with High Dose Cytosine Arabinoside (HDARAC). Leukemia & lymphoma, 4(2), 111-6. https://doi.org/10.3109/10428199109068053
Kempin, S, et al. "Treatment of Philadelphia Chromosome Positive (Ph +) Chronic Myelogenous Leukemia in Blast Crisis and Ph + Acute Leukemia with High Dose Cytosine Arabinoside (HDARAC)." Leukemia & lymphoma vol. 4,2 (1991): 111-6. doi: https://doi.org/10.3109/10428199109068053
Kempin S, Arlin Z, Berman E, Gee T, Mertelsmann R, Andreeff M, Kolitz J, Jhanwar S, Myers J, Clarkson B. Treatment of Philadelphia Chromosome Positive (Ph +) Chronic Myelogenous Leukemia in Blast Crisis and Ph + Acute Leukemia with High Dose Cytosine Arabinoside (HDARAC). Leuk Lymphoma. 1991;4(2):111-6. doi: 10.3109/10428199109068053. PMID: 27462940.
Copy Download .nbib Format: NLM
Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Ziemssen F, Wachtlin J, Kuehlewein L, Gamulescu MA, Bertelmann T, Feucht N, Voegeler J, Koch M, Liakopoulos S, Schmitz-Valckenberg S, Spital G.
PMID: 30288700
Diabetes Ther. 2018 Dec;9(6):2271-2289. doi: 10.1007/s13300-018-0513-2. Epub 2018 Oct 04.

INTRODUCTION: The prospective, non-interventional OCEAN study examined the use of intravitreal ranibizumab injections for the treatment of diabetic macular oedema (DME) in a real-world setting in Germany.METHODS: Adults with DME receiving ≥ 1 ranibizumab (0.5 mg) injections were recruited...

Cite
Ziemssen F, Wachtlin J, Kuehlewein L, et al. Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany. Diabetes Ther. 2018;9(6):2271-2289doi: 10.1007/s13300-018-0513-2.
Ziemssen, F., Wachtlin, J., Kuehlewein, L., Gamulescu, M. A., Bertelmann, T., Feucht, N., Voegeler, J., Koch, M., Liakopoulos, S., Schmitz-Valckenberg, S., Spital, G. (2018). Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany. Diabetes therapy : research, treatment and education of diabetes and related disorders, 9(6), 2271-2289. https://doi.org/10.1007/s13300-018-0513-2
Ziemssen, Focke, et al. "Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 9,6 (2018): 2271-2289. doi: https://doi.org/10.1007/s13300-018-0513-2
Ziemssen F, Wachtlin J, Kuehlewein L, Gamulescu MA, Bertelmann T, Feucht N, Voegeler J, Koch M, Liakopoulos S, Schmitz-Valckenberg S, Spital G. Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany. Diabetes Ther. 2018 Dec;9(6):2271-2289. doi: 10.1007/s13300-018-0513-2. Epub 2018 Oct 04. PMID: 30288700; PMCID: PMC6250630.
Copy Download .nbib Format: NLM
Short-term effects of relaxation music on patients suffering from primary open-angle glaucoma.

Clinical ophthalmology (Auckland, N.Z.)

Bertelmann T, Strempel I.
PMID: 26543350
Clin Ophthalmol. 2015 Oct 22;9:1981-8. doi: 10.2147/OPTH.S88732. eCollection 2015.

PURPOSE: To evaluate whether additive relaxation music (RM) has an adjuvant short-term effect on physiological and psychological parameters in patients with primary open-angle glaucoma.METHODS: Prospective, randomized clinical trial. Patients in the therapy group (TG) received a 30-minute RM via...

Cite
Bertelmann T, Strempel I. Short-term effects of relaxation music on patients suffering from primary open-angle glaucoma. Clin Ophthalmol. 2015;9:1981-8doi: 10.2147/OPTH.S88732.
Bertelmann, T., & Strempel, I. (2015). Short-term effects of relaxation music on patients suffering from primary open-angle glaucoma. Clinical ophthalmology (Auckland, N.Z.), 91981-8. https://doi.org/10.2147/OPTH.S88732
Bertelmann, Thomas, and Strempel, Ilse. "Short-term effects of relaxation music on patients suffering from primary open-angle glaucoma." Clinical ophthalmology (Auckland, N.Z.) vol. 9 (2015): 1981-8. doi: https://doi.org/10.2147/OPTH.S88732
Bertelmann T, Strempel I. Short-term effects of relaxation music on patients suffering from primary open-angle glaucoma. Clin Ophthalmol. 2015 Oct 22;9:1981-8. doi: 10.2147/OPTH.S88732. eCollection 2015. PMID: 26543350; PMCID: PMC4622524.
Copy Download .nbib Format: NLM
Is Optical Coherence Tomography a Useful Tool to Objectively Detect Actual Posterior Vitreous Adhesion Status?.

Case reports in ophthalmological medicine

Bertelmann T, Goos C, Sekundo W, Schulze S, Mennel S.
PMID: 26989538
Case Rep Ophthalmol Med. 2016;2016:3953147. doi: 10.1155/2016/3953147. Epub 2016 Feb 16.

Purpose. To objectively detect true posterior vitreous cortex (PVC) adhesion status using a commercially available swept-source OCT device (DRI OCT-1, Atlantis(©)). Material and Methods. Case report, review of the literature, and methodical discussion of concepts to improve OCT-guided PVC...

Cite
Bertelmann T, Goos C, Sekundo W, et al. Is Optical Coherence Tomography a Useful Tool to Objectively Detect Actual Posterior Vitreous Adhesion Status?. Case Rep Ophthalmol Med. 2016;2016:3953147doi: 10.1155/2016/3953147.
Bertelmann, T., Goos, C., Sekundo, W., Schulze, S., & Mennel, S. (2016). Is Optical Coherence Tomography a Useful Tool to Objectively Detect Actual Posterior Vitreous Adhesion Status?. Case reports in ophthalmological medicine, 20163953147. https://doi.org/10.1155/2016/3953147
Bertelmann, Thomas, et al. "Is Optical Coherence Tomography a Useful Tool to Objectively Detect Actual Posterior Vitreous Adhesion Status?." Case reports in ophthalmological medicine vol. 2016 (2016): 3953147. doi: https://doi.org/10.1155/2016/3953147
Bertelmann T, Goos C, Sekundo W, Schulze S, Mennel S. Is Optical Coherence Tomography a Useful Tool to Objectively Detect Actual Posterior Vitreous Adhesion Status?. Case Rep Ophthalmol Med. 2016;2016:3953147. doi: 10.1155/2016/3953147. Epub 2016 Feb 16. PMID: 26989538; PMCID: PMC4771875.
Copy Download .nbib Format: NLM
Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy.

Case reports in ophthalmology

Bertelmann T, Frank HU, Fuchs HA, Feltgen N.
PMID: 28559839
Case Rep Ophthalmol. 2017 Apr 28;8(1):271-278. doi: 10.1159/000475520. eCollection 2017.

PURPOSE: To report a case with ischemic macular edema (ME) due to an acute branch retinal vein occlusion (BRVO) which was treated with repeated intravitreal anti-VEGF injections.METHODS: Retrospective case presentation.RESULTS: A 66-year-old female patient was treated with repeated intravitreal...

Cite
Bertelmann T, Frank HU, Fuchs HA, et al. Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy. Case Rep Ophthalmol. 2017;8(1):271-278doi: 10.1159/000475520.
Bertelmann, T., Frank, H. U., Fuchs, H. A., & Feltgen, N. (2017). Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy. Case reports in ophthalmology, 8(1), 271-278. https://doi.org/10.1159/000475520
Bertelmann, Thomas, et al. "Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy." Case reports in ophthalmology vol. 8,1 (2017): 271-278. doi: https://doi.org/10.1159/000475520
Bertelmann T, Frank HU, Fuchs HA, Feltgen N. Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy. Case Rep Ophthalmol. 2017 Apr 28;8(1):271-278. doi: 10.1159/000475520. eCollection 2017. PMID: 28559839; PMCID: PMC5437432.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 38 entries